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Abstract
Background: Entry of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) and its envelope fusion with host cell
membrane are controlled by a series of complex molecular mechanisms, largely dependent on the viral envelope
glycoprotein Spike (S). There are still many unknowns on the implication of cellular factors that regulate the entry process.
Methodology/Principal Findings: We performed a yeast two-hybrid screen using as bait the carboxy-terminal endodomain
of S, which faces the cytosol during and after opening of the fusion pore at early stages of the virus life cycle. Here we show
that the ezrin membrane-actin linker interacts with S endodomain through the F1 lobe of its FERM domain and that both
the eight carboxy-terminal amino-acids and a membrane-proximal cysteine cluster of S endodomain are important for this
interaction in vitro. Interestingly, we found that ezrin is present at the site of entry of S-pseudotyped lentiviral particles in
Vero E6 cells. Targeting ezrin function by small interfering RNA increased S-mediated entry of pseudotyped particles in
epithelial cells. Furthermore, deletion of the eight carboxy-terminal amino acids of S enhanced S-pseudotyped particles
infection. Expression of the ezrin dominant negative FERM domain enhanced cell susceptibility to infection by SARS-CoV
and S-pseudotyped particles and potentiated S-dependent membrane fusion.
Conclusions/Significance: Ezrin interacts with SARS-CoV S endodomain and limits virus entry and fusion. Our data present a
novel mechanism involving a cellular factor in the regulation of S-dependent early events of infection.
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Introduction
Coronaviruses (CoV) are enveloped, single strand positive-sense
RNA viruses capable of infecting a wide range of birds and
mammals, including humans [1–5]. In 2003, the causative agent of
the severe acute respiratory syndrome (SARS) outbreak was
identified to be a novel, highly pathogenic, respiratory human
coronavirus, the SARS-CoV [6–9].
The viral envelope glycoprotein Spike (S) is a highly glycosy-
lated trimeric type I membrane protein, which forms the typical
spike structures at the envelope of coronaviruses. S is responsible
for binding to cellular receptors and envelope fusion with host cell
membranes. SARS-CoV S is 1255 amino-acids long. Although the
exact boundaries of S transmembrane domain are not clearly
defined, the N-terminal ectodomain and the C-terminal endodo-
main are most likely 1193 and 39 amino-acids long, respectively.
SARS-CoV S mediates binding to the virus’ cellular receptor, the
angiotensin-converting enzyme 2 (ACE-2) on apical surfaces of
epithelial cells [10,11]. S cleavage into S1 and S2 subunits by either
extracellular proteases [12] or the pH-sensitive endosomal protease
cathepsin-L [13] is a prerequisite for its fusogenicity. This cleavage
triggers the release of a hydrophobic fusion peptide at the N-terminal
end of the S2 subunit, which inserts itself into host membranes,
placing viral and cellular membranes at close proximity. S
conformational changes lead to the fusion of the viral envelope with
cellular membranes. Membrane destabilization by the S juxtamem-
brane domain, localized in the ectodomain, as well as clusters of
palmitoylated cysteines, found within the membrane-proximal half
of the S endodomain, may facilitate the fusion process [14,15].
A recent study has shown that a palmitoylation-null mutant S
protein is deficient for partitioning into detergent resistant
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membranes and for mediating S-dependent cell-cell fusion [16].
Other regions within the endodomain may also regulate fusion
and S-mediated entry into susceptible cells [17–19]. A C-terminal
truncation of 17 residues was shown to increase S-mediated cell-
to-cell fusion [17]; a truncation of the last 19 amino acids of S
resulted in higher levels of transduction of Vero cells by murine
leukemia virus (MLV) S-pseudotyped particles [19]. However it is
unclear whether cellular factors bind to S endodomain and
regulate fusogenicity.
S endodomains are accessible to cellular machineries i/ during
production, maturation, trafficking, and assembly of viral envelope
proteins (pre-budding steps), and ii/ at a critical stage of virus
entry, just after formation of the fusion pore, and after fusion. We
hypothesized that during these crucial stages of infection,
interactions between the S endodomain and cellular machineries
could participate in regulating infectivity and host cell susceptibil-
ity to infection.
We performed a yeast two-hybrid screening using S endodo-
main as bait. Here we describe for the first time the interaction
between SARS-CoV S endodomain and ezrin, a member of the
Ezrin/Radixin/Moesin (ERM) family of proteins. ERM have a
crucial role in organizing membrane domains through their ability
to interact with lipid rafts, transmembrane proteins and filamen-
tous actin [20]. Hence, they mediate a fine-tuned linkage that
strengthen the cell cortex, partition membrane clusters, and
regulate signal transduction pathways [20]. Recent studies suggest
that ezrin participates in the formation of either a diffusion barrier
or a tether, which limits mobility of membrane components, in
particular lipid rafts [21,22].
Ezrin is found in a cytosolic dormant state where the C-terminal
ERM-association domain, the C-ERMAD, and the N-terminal
FERM domains interact with each other, quenching protein
binding sites, and is activated through phosphatidyl-inositol 4,5
biphosphate binding and phosphorylation [20,23]. Activation
opens up the molecule and releases the FERM and C-ERMAD
domains, which are then free to interact with membranes
(phospholipids and endodomains of transmembrane proteins)
and signaling molecules, and actin cytoskeleton, respectively
[20,24,25]. Overexpression of the FERM domain of ezrin has a
dominant negative effect, by saturating ezrin binding sites at the
plasma membrane and inhibiting its interaction with actin by
blocking C-ERMAD sites [20,26].
Interestingly, viruses such as vaccinia virus and minute virus of
mice were shown to modulate the pathways in which ERM
proteins are involved to ensure viral entry and cell spreading,
respectively [27,28]. Furthermore, ERM proteins have been
shown to have differential regulating roles in retroviral life cycles,
depending on the viral step examined [29–32]. Therefore, ERM
proteins, which are crucial regulators of cell functions, may play
important roles at various stages of virus life cycles.
Our objectives were to confirm the interaction between SARS-
CoV S and ezrin and to study the role of ezrin in S-dependent
entry events. Here we show a novel restraining role of ezrin at
early stages of SARS-CoV replication cycle. We discuss the
relevance of our findings in the regulation of SARS-CoV entry in
host cells.
Results
The endodomain of the SARS-CoV S protein binds to the
F1 lobe of the FERM domain of ezrin in yeast
We hypothesized that cellular proteins may interact with the
carboxy-terminal endodomain of the S envelope protein and
either help or restrict processes involving S. To identify such
cellular factors, we performed a genomic yeast two-hybrid screen
using the SARS-CoV S endodomain as bait (Fig. 1A–B). A
random-primed cDNA library from human placenta was screened
and 233 positive clones were identified. The most prominent result
of the screen was the identification of the interaction between S
endodomain and the cellular protein ezrin (Fig. 1A, C) with a total
of 82 positive clones (35%) corresponding to this protein
(Accession number: NM_003379; Fig. 1C). The S - ezrin
interaction was classified with high confidence score (Predicted
Biological Score =A; Fig. 1A) and was not found in parallel
screens performed with other viral baits [33,34] and data not
shown). These data indicate that ezrin specifically interacts with
SARS-CoV S endodomain in yeast.
To determine the binding region of ezrin to S endodomain, the
82 ezrin cDNA sequences were aligned using ClustalW multiple
sequence alignment program. All ezrin cDNA shared a common
sequence of 264 base pairs corresponding to amino acids 6 to 93
(Fig. 1C). Interestingly, this region corresponds almost completely
to the F1 lobe of the N-terminal FERM domain (amino acids 2 to
82 [35], Fig. 1C and 1D). This suggests that interaction of ezrin
with S endodomain requires a complete F1 lobe. This region was
Figure 1. The F1 lobe of the ezrin FERM domain binds to the
SARS-CoV S endodomain. A. Table summarizing the yeast two-
hybrid screening results for ezrin - S endodomain interaction. B.
Schematic representation of the SARS-CoV S endodomain sequence
(not drawn to scale). S1: Subunit 1. S2: Subunit 2. TM: transmembrane
domain. endo: endodomain. C. Schematic representation of ezrin (not
drawn to scale). The bold line represents the common sequence of the
82 cDNAs corresponding to ezrin found in the yeast two-hybrid
screening. The domain was named ezrin F1/Spike Binding Domain
(SBD). F1, F2, and F3 represent approximate regions corresponding to
the three lobes of the FERM domain. T567: threonine 567. D.
Representation of the three-dimensional crystal structure of the ezrin
FERM domain, showing the three distinct globular lobes F1, F2, and F3.
The region in light grey represents amino-acids of the F1/SBD. The
FERM domain crystal structure for ezrin (PDB ID: 1NI2) was downloaded
from the Protein Data Bank (http://www.pdb.org). 3-D rendering of the
ezrin FERM domain was performed using MacPyMol software (DeLano
Scientific).
doi:10.1371/journal.pone.0049566.g001
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subsequently named ezrin F1/S Binding Domain or F1/SBD
(Fig. 1C).
S endodomain is sufficient to pull-down ezrin from
epithelial cell lysates
To confirm the interaction of S endodomain with human ezrin,
GST-pull down assays were performed. Briefly, we used GST-fused
S endodomain (GST-Sendo) protein bound to glutathione-coupled
sepharose beads to pull down endogenous ezrin protein from cell
lysates of HeLa human epithelial cells (Fig. 2A). Glutathione-
sepharose beads alone and GST protein fused to the ezrin FERM
domain and bound to beads (GST-FERM) were used as negative
and positive controls, respectively (Fig. 2A lanes 2–3). GST-FERM
was able to pull down ezrin from the HeLa lysate. This result was
expected as the FERM domain has the property to specifically
interact with the C-ERMAD of ezrin. Furthermore, GST-Sendo
could coprecipitate ezrin in a dose-dependent manner (Fig. 2A lanes
4, 5, 6). This result confirms the interaction of the SARS-CoV S
endodomain with the human ezrin protein.
We then decided to analyze the interaction of the S
endodomain with ezrin from the SARS-CoV-permissive Vero
E6 cell line. Similarly, the GST-Sendo could precipitate the Vero
E6 endogenous ezrin protein (Fig. 2B lanes 2–3). Incubation of
GST-Sendo with Vero E6 cell lysates in the presence of rabbit
serum against the endodomain of S significantly diminished the
interaction (Fig. 2B lanes 4–5). Moreover, GST protein alone was
not able to pull down ezrin (Fig. 2B lane 6), further confirming that
the 39 amino-acids of SARS-CoV S endodomain are responsible
for the interaction. These results collectively show that the S
endodomain is capable of interacting specifically with ezrin in vitro.
The last 8 carboxy-terminal residues and the membrane
proximal cysteine cluster of SARS-CoV S endodomain are
involved in ezrin binding in vitro
To map the amino-acids on S that are important for the
interaction with ezrin, we decided to construct a series of S
endodomain mutants and analyze their capacity to bind ezrin in
GST pull down assays (Fig. 3A). Analysis of the SARS-CoV S
endodomain sequence revealed three regions with distinctive
characteristics: a carboxy-terminal basic region (amino-acids
1248–1254), a central acidic stretch (amino-acids 1239–1244)
and a series of clusters of cysteine residues (amino-acids 1217–
1236). We reasoned that these regions could be involved in the
interaction with ezrin. First, we constructed truncation mutants by
deleting the carboxy-terminal regions either containing the basic
cluster or both the basic cluster and the acidic stretch. These
truncation mutants consisted in deletion of eight and nineteen
amino-acids, respectively (Sendo D8 and Sendo D19, Fig. 3A). As
expected, glutathione-conjugated beads and GST-coupled beads
could not pull down ezrin whereas beads coupled to GST-Sendo wt
could precipitate ezrin efficiently from a Vero E6 cell lysate
(Fig. 3B lanes 2–6). Both D8 and D19 truncations were able to
significantly diminish interaction with ezrin at similar levels, but
not abrogate it (Fig. 3B lanes 7, 8, 9, 10). These data show that the
eight carboxy-terminal amino-acid stretch, which is rich in basic
residues, is important for ezrin binding and that another motif in
the endodomain may contribute to the interaction. Conversely,
the acidic stretch does not seem involved in the interaction.
We then analyzed the implication of the nine cysteines in the
interaction with ezrin. These residues are found in the membrane
proximal region of the S endodomain. To simplify the analysis, we
decided to pool cysteines into four clusters, namely C1 to C4, of
two to three residues (Fig. 3A). While mutations of C2, C3, and C4
clusters had little impact on the interaction with ezrin (Fig. 3C
compare lanes 9–14 with lanes 5–6), mutation of the cluster C1
was able to almost completely abrogate the interaction (Fig. 3C
lanes 7–8). Consistently, mutation of all clusters of cysteines also
greatly reduced binding to ezrin (Fig. 3C lanes 15–16). This result
indicates that the C1 membrane proximal cysteine cluster is
important for binding to ezrin in vitro.
Since endodomain truncations and cysteine to alanine muta-
tions of the SARS-CoV S endodomain were found to diminish
interaction with ezrin individually, both types of modifications
were next tested simultaneously (Sendo D8 C1-4 and Sendo D19 C1-4).
Additionally, a truncation mutant was tested where the cysteine
cluster-containing portion (residues 1217 to 1236) of S endodo-
main was deleted (Sendo DC). Also, the positively-charged residue
lysine 1227 and the polar residue threonine 1220 were point-
mutated into alanines to investigate their possible involvement in
the S-ezrin interaction (Sendo K1227A and Sendo T1220A; Fig. 3A). As
expected, the DC truncation almost completely abrogated the
interaction with ezrin, although a faint band was still observed
further indicating that the C-terminal half of S endodomain
contains some interaction determinants (Fig. 3D lane 6). The point
mutation on the lysine K1227 did not significantly affect binding
with ezrin. The point mutation on the threonine T1220 had no
effect on binding with ezrin. Confirming our previous results, S
endodomain mutants containing both truncations (D8 or D19),
and the cysteine mutations (C1-4) were not able to bind ezrin
(Fig. 3D lanes 4–5). Together, these data show that the membrane
proximal cysteine cluster C1 and the last eight C-terminal residues
are important determinants of interaction of SARS-CoV S
endodomain with ezrin in vitro.
Ezrin is present at the site of entry of Spike-pseudotyped
lentiviral particle
Considering the major role of S in virus entry and membrane
fusion, we first assessed whether S endodomains could be
accessible to ezrin at early stages of infection. To mimic SARS-
CoV entry, we used Spike-pseudotyped lentiviral particles
Figure 2. In vitro confirmation of the interaction between SARS-
CoV S endodomain and ezrin. A. The endodomain of S pulls down
ezrin from HeLa cell lysate. Cell lysate was incubated with Glutathione-
Sepharose beads either uncoupled (lane 2) or coupled with the fusion
protein GST-FERM (positive control, lane 3) or increasing amounts of
GST-Sendo (lanes 4–6). B. The endodomain of S pulls down ezrin from
Vero E6 cell lysate. Similarly, cell lysate was incubated with Glutathione-
Sepharose beads bound either to GST fused to Sendo in absence (lanes
2–3) or presence (lanes 4–5) of rabbit serum that recognizes the
endodomain of S, or to GST alone (lane 6). For both A. and B. 10 mL of
cell lysate was used as input control which represents 1.6% and 4% of
the volume used for the pull down for A. and B., respectively. IB:
Immunoblot. Results shown are representative of two independent
experiments.
doi:10.1371/journal.pone.0049566.g002
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(SARSpp), which were previously shown to enter cells in an ACE-
2, cathepsin-L, and low pH dependent pathway, faithfully
recapitulating the entry process of native SARS-CoV virions
[36–39]. Vero E6 epithelial cells stably expressing RFP-ezrin
fusion protein were infected with GFP-Vpr SARSpp. At 30 min-
utes post-infection, cells were analyzed using a total internal
reflection fluorescence microscope (TIRFM) to visualize events
occurring at proximity of the plasma membrane and minimize
background from the other layers of the cells. Green dots
corresponding to GFP-Vpr SARSpp were readily observed and
found associated with RFP-ezrin enriched domains (Fig. 4, white
arrowheads, Supporting movie S1). This result indicates that ezrin
is present at sites of SARSpp entry, possibly coating endosomes
following internalization of particles. Similar data were obtained
using a spinning disc confocal microscope on live cells expressing
RFP-ezrin (data not shown). This would suggest that after the
formation of the fusion pore, S endodomains facing the host cell
cytosol have the possibility to interact with ezrin molecules.
Knock down of ezrin by siRNA increases SARS-CoV S-
mediated entry
To investigate the potential role of ezrin in S-dependent entry,
we decided to silence the expression of ezrin by specific siRNA.
HeLa-F5 cells, stably expressing the SARS-CoV receptor ACE2,
were transfected with siRNAs that target ezrin mRNA or non-
targeting control siRNAs. The ezrin siRNA transfection decreased
expression significantly, with a quantified 80% knock down at the
protein level (Fig. 5A). Ezrin siRNA was shown to slightly increase
transduction levels by Denvpp and VSVGpp (around 3- and 5-fold
increases, respectively) (Fig. 5B). Interestingly, the highest fold-
change observed was for SARSpp where S-mediated entry was
enhanced more than 12-fold. These data indicate that ezrin
expression silencing has a slight enhancing effect on entry of viral
particles uptake in general, as well as a more specific highly
increasing effect on entry of SARS-CoV S pseudotyped particles.
This suggests a negative regulatory role for ezrin in SARS-CoV S-
mediated entry.
Mutation of the ezrin-binding domain on S endodomain
favors SARSpp entry into Vero E6 cell
To confirm that ezrin binding to S endodomain negatively
regulates SARSpp entry, we have generated mutated SARS-CoV
S proteins that contain modified endodomains and pseudotyped
them. The mutated SARS S pseudotyped particles were designed
by taking into account the biochemical pull-down data we have
established (Fig. 3). To completely abolish ezrin interaction, we
constructed a S mutant with cysteine to alanine mutations of the
first cysteine cluster and with a deletion of the last 8 amino acids
(SD8 C1). Considering that the C1 mutation could have severe
consequences on fusion [14], we also generated a second S mutant
with only a deletion of the 8 last amino acids of the C-terminus
(SD8), a modification which should partially alter interaction with
ezrin. SD8 and SD8 C1 S proteins could be incorporated into
lentiviral particles (Fig. 6A, upper panel) and similar amounts of
particles were found in concentrated supernatants, as indicated by
detection of the HIV p24 protein (Fig. 6A, lower panel). Levels of
Figure 3. Characterization of interactions determinants of S
endodomain binding to ezrin. A. Sequences of the wild type (wt)
and mutated S endodomain used in the GST-pull down analysis. Twelve
GST fusion proteins were produced with mutations in the S
endodomain. D indicates truncations and C indicates cysteine to
alanine mutations (in bold) of cysteine clusters (1 to 4). B. & C. Effect of
truncations or cysteine to alanine mutations. Vero E6 lysate was
incubated with Glutathione-Sepharose beads coupled or not with GST,
GST-Sendo wt (B. & C.), GST-Sendo D8, and GST-Sendo D19(B.), GST-Sendo C1,
GST-Sendo C2, GST-Sendo C3, GST-Sendo C4, and GST-Sendo C1-4 (C.) using 1
or 5 mg of GST fusion proteins. D. Effects of cysteine to alanine
mutations and truncations or point mutations (K1227A and T1220A).
Vero E6 lysate was incubated with Glutathione-Sepharose beads
coupled with either GST, GST-Sendo wt, GST-Sendo D8 C1-4, and
GST-Sendo D19 C1-4, GST-Sendo DC, GST-Sendo K1227A, GST-Sendo T1220A using
1 mg of each GST fusion protein. 5 mL of cell lysate was used as input
control for B. & C. (8% of volume used in each pull down); 10 mL of cell
lysate was used as input control for D. (5% of volume used in each pull
down). IB: Immunoblot. Results shown are representative of two
independent experiments.
doi:10.1371/journal.pone.0049566.g003
Figure 4. Ezrin accumulates at sites of entry of SARS-CoV S
pseudotyped particles. Vero E6 cells stably expressing RFP-ezrin
were inoculated with SARS-CoV S-pseudotyped lentiviral particles
harboring a GFP-tagged Vpr protein (SARSpp GFP-Vpr) on ice for
30 minutes. Unbound particles were washed. Internalization of particles
was induced by placing the culture dish in a 37uC 5% CO2 chamber. At
30 minutes post temperature switch (t = 0), cells were analyzed by
TIRFM. Time-lapse images were acquired every 3 seconds. The whole
cell (first frame) is shown on the left panel. The region shown for time-
lapse images is indicated by a square. 3 frames at t = 33, 78 and
108 seconds out of a total of 50 frames are shown and correspond to
the times after the start of image acquisitions. The movie of this image
sequence is shown as supporting material (Supporting movie S1). Scale
bar = 40 mm.
doi:10.1371/journal.pone.0049566.g004
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incorporation of wt S, SD8 and SD8 C1 were quantified by
densitometry and normalized to p24 levels. The ratio of S
incorporation was 1 : 2.5 : 3.9 for wt S, SD8 and SD8 C1,
respectively. Entry of mutated S pseudotyped particles along with
wt S SARSpp was analyzed in SARS-CoV-susceptible Vero E6
cells (Fig. 6B). Both mutated SARSpp were found to transduce
Vero E6 cells more efficiently than wt S SARSpp. Although
mutation of C1 is expected to induce a defect in fusion [14], a 2-
fold increase in transduction was measured for SD8 C1 SARSpp.
This increase can be explained by both the efficient incorporation
of SD8 C1 in pseudotyped particles and the lack of interaction
with ezrin. Interestingly, significantly higher levels of transduction
were observed for the SD8 SARSpp, with an increase of
transduction of approximately 11-fold compared to wt S SARSpp.
This result is in agreement with previously published data where
murine leukemia virus (MLV)-based SD8 SARSpp were found to
transduce Vero cells more efficiently than wt S pseudotyped
particles [19]. In our study, better incorporation of SD8 could be
in part responsible for the increase of transduction. However, the
difference in fold-change that was observed for SD8 incorporation
into pseudoparticles and cellular transduction (2-fold compared to
11-fold increase, respectively) suggests that partial disruption of
interaction with ezrin contributes to this enhancement of
transduction. Taken together, these data are in agreement with
the hypothesis that ezrin binding to S endodomain decreases entry
of viral particles.
Expression of the ezrin FERM domain increases
susceptibility of Vero E6 cells to SARS-CoV infection
To further study the role of ezrin during SARS-CoV infection,
we produced clonal Vero E6 stable cell lines that either express
wild-type ezrin (ezrinwt) or the N-terminal FERM domain of ezrin
(ezrinFERM) fused to the green fluorescent protein (GFP). The
latter form of ezrin is known to have a dominant negative effect on
endogenous ezrin [26]. The levels of expression and subcellular
localization of GFP-ezrinwt and GFP-ezrinFERM in selected clones
were monitored by flow cytometry and fluorescence microscopy,
respectively (Fig. 7A a–b). Flow cytometry analysis showed that
clones GFP-ezrinwt and GFP-ezrinFERM had means of fluores-
cence intensities of 26103 and 76102, respectively (Fig. 7A a). As
expected, GFP-ezrinwt distributed in the cell cytosol with
occasional enrichments at the cell cortex, whereas GFP-ezrinFERM
was almost exclusively found at the cell cortex, in membrane
ruffles and lamellipodia (Fig. 7A b). We verified that Vero E6, and
clones GFP-ezrinwt and GFP-ezrinFERM expressed similar levels of
ACE-2 receptor at cell surface (data not shown).
The stable cell lines and control Vero E6 cells were first infected
with SARS-CoV. Infection levels were then monitored by
quantitative real-time PCR (qRT-PCR) on the viral N gene at
3, 6 and 24 hours post infection (Fig. 7B) and by immunofluo-
rescence assay at 24 hours post-infection (Fig. 7C). During the
whole time course of infection, levels of N RNAs measured in
infected GFP-ezrinwt cells were comparable to those counted for
control Vero E6 cells (Fig. 7B). Normalized N levels at early time
points ranged between 3.26104 and 3.66104 and reached
approximately 2.66106 at 24 hours post-infection for these two
cell lines (,2 log increase between 6 and 24 hours). Interestingly,
although the replication rate at 24 hours was lower in clone GFP-
ezrinFERM than control Vero E6 cells (normalized N levels of
Figure 5. Knock down of ezrin by siRNA increases entry of
SARS-CoV S pseudotyped particles. A. Ezrin expression knock
down by siRNA. HeLa-F5 cells stably expressing the SARS-CoV receptor
ACE2 were transfected twice with ezrin or non-targeting siRNAs and
knock down efficiency was estimated by Western blot analysis of ezrin
and actin content of cell lysates. B. Luciferase activity fold change
analysis. HeLa-F5 cells treated with siRNAs as indicated above were
infected with pseudotyped lentiviral particles harboring the VSV G or
SARS-CoV S viral envelope glycoproteins. Denvpp indicates lentiviral
particles without any viral surface glycoprotein. The fold change in
luciferase activity was calculated using the non-targeting siRNA
condition as negative control. Experiments were performed in
triplicates and the results of this experiment are representative of at
least three independent experiments. ** indicates a value of p,0.001 in
two-tailed t-tests.
doi:10.1371/journal.pone.0049566.g005
Figure 6. S C-terminal mutations that decrease ezrin interac-
tion enhance transduction by pseudotyped particles in Vero E6
cells. A. Generation of lentiviral pseudotyped particles harboring wild-
type (wt) or mutated (D8 and D8 C1) SARS-CoV Spike proteins. A
Western blot assay was performed on concentrated SARSpp particles
where the Spike protein and the lentiviral backbone protein p24 were
probed. Estimation of protein quantities was performed using
densitometry analysis. B. Entry of wt and mutated SARS-CoV S
pseudotyped particles. Vero E6 cells were infected by wt S SARS-CoV
pseudotyped particles, along with mutated SARSpp (SD8 SARSpp and
SD8 C1 SARSpp). Results are expressed as fold-change in luciferase
activity compared to the wt S SARSpp. The results are averages of
triplicates and are representative of at least three independent
experiments. * indicates a value of p,0.05 in a two-tailed t-test.
doi:10.1371/journal.pone.0049566.g006
Implication of Ezrin in SARS Coronavirus Infection
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16106), a slight enhancement was observed at early time points
(normalized N RNAs ranged between 5.26104 and 66104).
Similar profiles were observed for qRT-PCR on viral ORF1b
(data not shown). This result shows that expression of the
dominant negative FERM domain of ezrin slightly enhances
early, but not late stages of infection.
In parallel to qRT-PCR analysis, cells were analyzed by
immunolabeling and fluorescence microscopy at 24 hours post-
infection (Fig. 7C a). S was labeled to mark infected cells. All cells
were stained for either actin or nuclei. For each cell line, the
percentage of infected cells was calculated (Fig. 7C b). Infection
rates in Vero E6 and Vero E6 GFP-ezrinwt cells were similar with
2.5% of S-positive cells. Interestingly, a 5.8-fold increase in the
percentage of infected cells (15% of cells) was observed for the
GFP-ezrinFERM cell line, when compared with control cells. This
higher susceptibility to infection is consistent with higher levels of
N RNAs detected at early time points post-infection for the clone
GFP-ezrinFERM. These data indicate that partial disruption of
ezrin function by expression of its dominant negative form
increases host cell susceptibility to infection.
Expression of the ezrin FERM domain increases S-
mediated entry
To verify that the enhanced permissiveness to SARS-CoV
infection observed in cells expressing the ezrin FERM domain is
due to a higher efficiency of entry of virions, we investigated levels
of transduction of control, GFP-ezrinwt and GFP-ezrinFERM clonal
Vero E6 cells by SARSpp (Fig. 8A). Interestingly, whereas the
transduction level of GFP-ezrinwt was not significantly different
Figure 7. Expression of the FERM domain of ezrin increases Vero E6 cell susceptibility to SARS-CoV infection. A. Flow cytometry
analysis (a.) and subcellular localization (b.) of the wt or FERM domain GFP-ezrin in clonal Vero E6 stable cell lines. (b.) Arrows indicate enrichments of
wt or FERM ezrin. Scale bars: 20 mm. B. Time course of SARS-CoV replication in Vero E6 stable cell lines expressing wt or FERM GFP-ezrin. Vero E6, Vero
E6 GFP-ezrinwt, Vero E6 GFP-ezrinFERM were infected with SARS-CoV (strain HK39849) at M.O.I. 5. At 3, 6 and 24 hours post infection, SARS-CoV N RNA
levels were measured using qRT-PCR with 18S rRNA normalization. For each condition the average of two measurements of two independent wells
was calculated. C. SARS-CoV infection rates in Vero E6, Vero E6 GFP-ezrinwt and Vero E6 GFP-ezrinFERM cell lines. Cells were infected with SARS-CoV
(strain HK39849) at M.O.I. of 5. 24 h post-infection, cells were immunolabeled for SARS-CoV S. (a.), scale bars: 100 mm. (b.) for each cell line, images of
ten random microscopy fields were acquired and analyzed for total number of cells (n; DAPI or Phalloidin AMCA staining) and SARS-CoV S positive
cells (TRITC staining) using Imaris 6.3 software. ** indicates a value of p,0.001 in two-tailed t-tests.
doi:10.1371/journal.pone.0049566.g007
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than in control Vero E6 cells, GFP-ezrinFERM cells showed a ,15-
fold increase in luciferase activity values. This result indicates that
clone GFP-ezrinFERM is more permissive to SARS-CoV S-
mediated entry and is consistent with the higher rates of infection
observed with SARS-CoV in this cell line (Fig. 7B–C).
To exclude a clonal effect, a new batch of polyclonal Vero E6
cells expressing GFP-ezrinFERM was generated. As control, we
used Vero E6 cells transduced to express a non-relevant HcRed
protein. Expression level of GFP-ezrinFERM was monitored by flow
cytometry (Fig. 8B a). These cells were used to carry out infections
using SARSpp (Fig. 8B b). Consistently with previous data on
clonal cell lines, polyclonal cells expressing GFP-ezrinFERM
showed a 9-fold increase in luciferase activity, indicating higher
susceptibility to SARSpp infection. Of note, SARSpp infection was
not enhanced in cells selected to express high amounts of GFP-
ezrinFERM (data not shown). Altogether, our data indicate that
partial disruption of ezrin activity by expression of low levels of
GFP-ezrinFERM enhances cell susceptibility to S-mediated entry
and support a restraining role of ezrin at this stage.
Expression of the FERM domain of ezrin by target cells
enhances S-mediated cell-cell fusion
Our previous functional experiments have demonstrated a
negative regulatory role for ezrin during S-mediated entry. To
characterize further this phenomenon, we questioned whether
ezrin could be involved in the S-mediated fusion process, during
which S endodomains become accessible to the cytosol. To that
end, we chose to study the effect of expression of the FERM
domain of ezrin on S-dependent fusogenicity in an in vitro cell-cell
fusion assay. In this experiment, HeLa cells stably expressing both
S and a HcRed fluorescent marker (HeLa HcRed Spike) were co-
incubated with GFP, GFP-ezrinwt or GFP-ezrinFERM Vero E6
stable cell lines. As expected, control HeLa HcRed cells were not
able to fuse with any of the three Vero E6 cell lines, as no syncytia
were found (Fig. 9A panels a to c). Similarly, no syncytia were
observed for HeLa HcRed Spike cells incubated with Vero E6
stable cell lines but not activated by trypsin treatment (Fig. 9A
panels d, f and h). Conversely, about 4.5% of nuclei were found in
syncytia when HeLa HcRed Spike cells were incubated in
presence of either GFP or GFP-ezrinwt Vero E6 cells after trypsin
activation (Fig. 9A panels e and g and Fig. 9B). Interestingly, 8% of
nuclei were found to be in syncytia in the condition where HeLa
HcRed Spike cells were co-cultured with GFP-ezrinFERM cells
after trypsin activation (Fig. 9A panel i and Fig. 9B). This 2-fold
increase of fusion, linked to expression of GFP-ezrinFERM in target
cells, was consistently found in four independent experiments. This
result shows that target cells expressing the FERM domain of ezrin
are more susceptible to S-dependent cell-cell fusion and further
indicates that ezrin plays a restrictive role during SARS-CoV S-
dependent fusion process.
Discussion
Our data demonstrate for the first time an interaction between
the membrane tethering protein ezrin and the endodomain of the
SARS-CoV S envelope glycoprotein and describe a novel
mechanism involving ezrin as a restraining factor of SARS-CoV
entry. We show that ezrin, by binding to S endodomain, limits S-
dependent early events of infection, most likely by affecting
efficacy of fusion. Our data point towards a novel role of ezrin as a
regulator of early events of infection of susceptible cells by SARS-
CoV.
SARS-CoV S endodomain interaction with ezri
Ezrin was identified for its interaction with the SARS-CoV
Spike endodomain by yeast two-hybrid screening (Fig. 1A).
Analysis of sequences of prey hits has shown that the F1 lobe of
the N-terminal FERM domain of ezrin mediates interaction with
S endodomain (Fig. 1C–D). FERM lobes of a number of FERM-
domain containing proteins have been described as mediating
specific interactions with proteins or phospholipids at the plasma
membrane. For example, a region located between the F1 and F3
lobes is the site where inositol-(1,4,5)-triphosphate (IP3) interacts
with the FERM domain of radixin [40]. Moreover, crystallo-
graphic data have shown that sites within the F3 lobe of radixin
are the binding regions of CD44 cytoplasmic region [41] and
ICAM-2 [42]. In addition, moesin F3 lobe was found to interact
with the EBP50 scaffolding protein [43].
Interestingly, radixin, which shares 76% amino-acid sequence
identity with ezrin [24], was also identified in the yeast two-hybrid
screening for its interaction with S endodomain, albeit with a
lower Predicted Biological Score (B), and only three independent
clones were found. The functional experiments presented here
focused on ezrin exclusively; however, the fact that radixin was
Figure 8. Expression of the FERM domain of ezrin enhances
entry of SARS-CoV S pp. A. Vero E6, Vero E6 GFP-ezrinwt and Vero E6
GFP-ezrinFERM clonal cells were infected with SARSpp and incubated for
72 hours and the activity of luciferase was measured (results
correspond to average of triplicates). B. (a.) Flow cytometry analysis of
polyclonal Vero E6 stable cells expressing GFP-ezrinFERM. Lentiviral
vector transductions enabled Vero E6 cells to express irrelevant HcRed
or GFP-ezrinFERM proteins. MFI: Mean Fluorescence Intensity. (b.)
Polyclonal Vero E6 cells stably expressing HcRed (negative control) or
GFP-ezrinFERM were infected with SARSpp, incubated for 72 hours, and
the activity of luciferase was measured. The results of this experiment
are representative of at least three independent experiments. *
indicates a value of p,0.05 in two-tailed t-tests.
doi:10.1371/journal.pone.0049566.g008
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found in the screen suggests that other ERMs could be implicated
in the life cycle of SARS-CoV. Furthermore, it was shown recently
that ezrin, radixin, and moesin play differential roles in the life
cycle of HIV-1, with some reports demonstrating that ERMs may
negatively regulate post-entry events by affecting stable microtu-
bules, and others that show ezrin and moesin as important for
entry events of the virus [29–32]. Experiments on radixin and
moesin should be performed to further investigate whether other
ERMs have a role in the SARS-CoV life cycle.
Confirmation of SARS-CoV S endodomain - ezrin
interaction and characterization of interaction
determinant
GST-pull down assays (Fig. 2) showed that the S endodomain of
SARS-CoV could pull down ezrin from HeLa and Vero E6
lysates, providing evidence of specific interaction between both
partners. Attempts of coimmunoprecipitation using full length
SARS-CoV S and ezrin have not been successful. Difficulty to
coimmunoprecipitate ERM proteins in our and others’ studies
could be due to the low proportion of activated proteins in cells,
which, moreover, interact with actin and are therefore insoluble.
GST-pull down assays using a series of GST-S endodomain
mutants demonstrated that residues in the last 8 amino-acids as
well as cysteines (particularly the juxtamembrane-most first cluster
C1) were important determinants for binding with ezrin (Fig. 3).
The positively charged amino-acids found in the very last 8 amino-
acids contain a KxHxx dibasic motif that was shown to function as
an ER retrieval signal [44,45]. The positively charged amino-acids
were of particular interest in our study as ERM proteins have been
shown to interact with the C-terminal tails of transmembrane
protein that contain juxtamembrane stretches of positively charged
amino-acids [46]. The finding that the C1 cluster of S
endodomain is also involved in ezrin binding in vitro is intriguing.
Cysteine residues are highly conserved among coronaviral Spike
proteins. SARS-CoV S cysteines are known to be palmitoylated
and important for S association with detergent-insoluble cellular
fractions and S-dependent cell-cell fusion [14,16]. It could be
argued that the GST-Sendo proteins, which have been purified
from bacteria in our study, may not reflect the palmitoylation state
of S. Whether a small fraction of S C1 clusters is not palmitoylated
and free to interact with ezrin in vivo would need further
investigation.
Ezrin is present at the site of virus fusion
Analysis of GFP-Vpr SARSpp entry in Vero E6 cells by TIRF
microscopy has revealed that after binding and endocytosis, RFP-
ezrin could be associated around some of the internalized particles,
perhaps surrounding the endosomal membrane (Fig. 4). Although
recruitment of ezrin around endosomal membranes may not be
specific to SARS particles’ internalization, our result suggests that
ezrin is present at the SARS-CoV fusion site. It is therefore
plausible that following initiation of the pore opening, ezrin
molecules come into contact with some newly accessible S
Figure 9. Effect of wt or FERM ezrin expression on S-mediated
cell-cell fusion. A. Microscopy analysis of syncytia formation induced
by activated SARS-CoV S. Vero E6 GFP, Vero E6 GFP-ezrinwt and Vero E6
GFP-ezrinFERM cells were overlaid on HeLa cells stably expressing HcRed
alone or HcRed and SARS-CoV S. SARS-CoV S was activated or not with
trypsin for 15 minutes (+Trypsin). 18 hours later, cells were fixed, nuclei
stained with DAPI and analyzed by microscopy for syncytia. Arrows
indicate syncytia. B. Quantification of syncytia. For the conditions in
which HeLa HcRed Spike cells (+Trypsin) were incubated with Vero E6
GFP or Vero E6 GFP-ezrinwt or Vero E6 GFP-ezrinFERM cells, 10 random
microscopy fields were analyzed for total number of nuclei (DAPI) and
number of nuclei in multi-nucleated cells (DAPI/HcRed/GFP). Results are
representative of three independent experiments. ** indicates a value
of p,0.001 in two-tailed t-tests.
doi:10.1371/journal.pone.0049566.g009
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endodomains. Topologically, an interaction between ezrin and S
endodomains requires that the fusion pore be open. Knowing the
function of ezrin in regulation of membrane fluidity, one could
expect that ezrin modulates the efficacy of fusion at a step
following the opening of the pore.
Reduction of cellular levels of ezrin enhances S-mediated
entry
We first studied the role of ezrin in S-mediated entry of
SARSpp. Reduction of cellular levels of ezrin by gene silencing
induced a marked increase in susceptibility to SARSpp by more
than 12-fold (Fig. 5). Our results also show that silencing ezrin
expression enhances, to a lower extent, entry of pseudotyped
particles with no envelope or VSV G. A slight ,2-fold increase in
entry levels for HIV-gp-pseudotyped particles has also been
observed (Supporting Fig. S1). No significant increase has been
detected for influenza virus HA-pseudotyped particles. These
enhancements have consistently been found to be lower than the
one found for SARS-CoV S-mediated entry. The moderate
enhancement effect of ezrin depletion by siRNA treatment on
VSV G and HIV-gp pseudotyped particles suggests that ezrin may
also have a general restricting effect on viral entry. Ezrin is a
scaffolding protein that links actin cytoskeleton and cholesterol-
rich lipid domains at the plasma membrane. It contributes to
membrane structure and organization. First, ezrin provides rigidity
to specific cortical areas of the cell by linking membranes to
cortical actin. For instance, ezrin is important for extensions of
lamellipodia and filopodia [47,48]. Second, ezrin enables the
organization of membrane microdomains by controlling fluidity of
membrane components. This process is extremely important in
the regulation of signalization by trans-membrane receptors and
signaling molecules [49–51]. Moreover, ezrin enables the com-
partmentalization of signaling molecules into microclusters and
prevents their free movement to restrict signaling. This has been
well described for the B and T cell receptors [50,52]. Therefore, it
is possible that the membrane rigidity induced by ezrin limits viral
entry in general, with a more important effect on SARS-CoV S-
mediated entry, due to the specific interaction with S.
Of note, ezrin was also identified as a strong enhancer of SARS-
CoV S-mediated entry in an independent functional siRNA
library screen performed in the laboratory (Dr. Dongjiang Tang,
Dr. Peigang Wang, BN, unpublished data). In this study, a library
targeting 122 cellular genes implicated in cellular trafficking was
used to characterize cell factors that regulate SARSpp entry.
Remarkably, ezrin siRNAs had the second-most enhancing effect.
Mutation of the S protein ezrin-binding domain is
associated with an increase of SARSpp transduction level
The deletion of the last 8 amino acids of the S protein, which
was shown biochemically to decrease interaction with ezrin (Fig. 3),
allowed pseudotyped particles to achieve higher transducing levels
than wt S SARSpp (Fig. 6). This finding further supports the
notion that ezrin’s interaction with S negatively modulates entry,
although we may not exclude the possibility that higher S
incorporation observed in the case of SD8 SARSpp also
contributes in increasing viral entry. Effects of truncations of S
endodomain have been analyzed in several independent studies.
Petit et al. have shown that a truncated S lacking the 8 C-terminal
amino-acids, named T1247 in their study, was less efficient in
mediating S-driven cell-cell fusion than wt S (34.01% of wt S) [17].
This was explained by an altered surface expression of S T1247
(79.15% of wt S). In another study by Giroglou et al., although low
cell surface expression of SD8 was also documented in 293T cells,
SD8 SARS-MLV pseudotyped particles could be produced and
could transduce Vero cells ,10-fold more than wt S SARS-
MLVpp [19]. In addition, deletion of the last C-terminal 17 amino
acids increased S-mediated cell-cell fusion [17] and SD19 mutants
were shown to be efficiently expressed at the cell surface of 293T
pseudotyped particles producer cells and induced a 100-fold
increase in transduction of Vero cells [19]. A study by Moore et al.
has shown that a S protein variant with a deletion of the last C-
terminal 27 amino-acids and addition of the eight most
membrane-proximal residues of the HIV-1 envelope glycoprotein
cytoplasmic domain (S-H2 in this study) induces better cell surface
expression, incorporation into simian immunodeficiency virus
(SIV) pseudotyped particles and capacity to mediate transduction
by SIVpp than wt S [18]. The authors concluded that the greater
efficiency of transduction of S-H2 pseudotyped particles compared
to wt S SARS-SIVpp was likely due to preferential incorporation
of S-H2. Further truncations altering cysteine residues have
resulted in decreased transduction levels [18,19] and deficiencies
in cell-cell fusion [14]. Interestingly, in our study we found that
SD8 C1 SARSpp could transduce slightly more potently Vero E6
cells than wt S SARSpp (Fig. 6). We have shown that SD8 C1 can
no longer bind ezrin in vitro (Fig. 3). SD8 C1 was better
incorporated into HIVpp than wt S (3.9-fold difference). The
higher incorporation level could be partly responsible for the
enhancement of transduction. However, the contribution of the
absence of ezrin binding cannot be excluded in the observed
enhancement of SD8 C1 SARSpp entry. Our work indicates that,
in addition to the levels of S incorporation into pseudotyped
particles and S fusogenicity, binding to ezrin may also contribute
to modulate the efficiency of S-mediated entry.
Expression of the dominant negative FERM domain of
ezrin increases host cell susceptibility to infection by
SARS-CoV and SARSpp and S-mediated cell-cell fusion
Expression of the dominant negative N-terminal FERM domain
of ezrin in Vero E6 cells was used to investigate the consequences
of ezrin function disruption on the host cell susceptibility to SARS-
CoV infection and entry of SARSpp. Replication levels and rates
of infection were similar for Vero E6 and Vero E6 cells expressing
GFP-ezrinwt (Fig. 7B–C). When the FERM domain of ezrin was
expressed, cell susceptibility to infection was enhanced with either
SARS-CoV or SARSpp (Fig. 7 and 8), further indicating that
ezrin’s restricting role on SARS-CoV infection takes place at the
entry step. We speculate that ezrin acts at the fusion stage, as cells
expressing GFP-ezrinFERM were twice more susceptible to fuse
with S-expressing HeLa cells than GFP or GFP-ezrinwt Vero E6
cells (Fig. 9). Interestingly, in these experiments expression of GFP-
ezrinwt did not inhibit infection or fusion. As ezrin is naturally
abundantly expressed in the cells used in this study, moderate
expression of GFP-ezrinwt has no effect simply because it does not
change massively the overall cellular content of ezrin. In other
experiments, we have observed that significant overexpression of
GFP-ezrinwt was able to enhance SARSpp transduction (data not
shown). We speculate that massive overexpression of GFP-ezrinwt
has consequences on ezrin functions in the cell that can ultimately
impact SARSpp entry. The use the dominant negative FERM
domain or of siRNA appears to be more relevant to study the role
of ezrin.
The fact that the replication level measured by qRT-PCR was
slightly lower in the clone expressing the FERM domain of ezrin
than control cells at 24 hours post-infection (Fig. 7B) suggests that
although ezrin restricts the rate of infection at early time points, its
function may be important for later stages. Alternatively, cell
fitness may be affected in FERM expressing cells, affecting virus
Implication of Ezrin in SARS Coronavirus Infection
PLOS ONE | www.plosone.org 9 November 2012 | Volume 7 | Issue 11 | e49566
replication rate. We have investigated the potential involvement of
ezrin on viral release using the SARS S, M, N and E-containing
virus-like (VLP) particle system developed in the laboratory [53].
While we could not detect ezrin at sites of VLP budding, we have
found presence of ezrin in preparations of purified VLPs.
However, this incorporation was S-independent and expression
of ezrinFERM had no impact on release of VLPs (data not shown).
Recent studies on influenza HA and baculovirus gp64 viral
glycoprotein-induced fusion have revealed that while the initial
pore formation step is mainly controlled by the fusion protein, the
subsequent steps of widening of the pore is a complex, multi-step
mechanism involving cell metabolism and components, in
particular membrane-curvature generating proteins [54,55].
Interestingly, it was shown that the actin cytoskeleton restricts
the opening of the fusion pore, and disrupting the actin network
enhances fusion pore widening [55]. In light of this, it would be
interesting to study ezrin’s role in the fusion pore expansion
induced by SARS-CoV S, considering the role of ezrin as a key
actin-membrane linker and its interaction with SARS-CoV S
endodomain after the fusion pore opening.
The present study has put to light an interaction between the
SARS-CoV S endodomain and the plasma membrane-actin linker
ezrin. Although direct evidence of the interaction occurring during
early stages of SARS-CoV infection has yet to be demonstrated,
our functional analysis reveals that ezrin has a limiting effect on
SARS-CoV entry. Owing to topological constraints, we can put
forward that ezrin binding to SARS-CoV S endodomain would
occur during the fusion process, after the opening of the fusion
pore. The findings that disruption of ezrin function enhances
SARS-CoV S-dependent entry and S-mediated cell-cell fusion,
would point towards a model in which ezrin scaffolds interactions
with S endodomains, impose a limitation on membrane fluidity
and act as a physical constraint restraining completion of fusion.
The data shown here provides the basis for the establishment of a
new mechanism of regulation by ezrin in the entry process of
SARS-CoV.
Materials and Methods
Cell
The African green monkey kidney Vero E6, human embryonic
kidney (HEK) 293T, human cervix carcinoma HeLa cell lines
(ATCC, Manassas, VA, USA), and HeLa-F5, which stably express
ACE2 [10], were used in this study.
Antibodies
Rabbit polyclonal serum against the endodomain of SARS-CoV
S was from Proscience (Poway, CA, USA). Mouse polyclonal
serum against the SARS-CoV S was previously described [56].
Polyclonal rabbit anti-ezrin was a generous gift from Dr. Monique
Arpin (Institut Curie, Paris, France) [57]. Goat anti-beta-actin
antibody was purchased from Santa Cruz Biotechnologies (Santa
Cruz, CA, USA). Anti-p24 antibodies were from Abcam (Hong
Kong SAR, China). The secondary antibodies used were TRITC-
conjugated goat anti-mouse IgG (Zymed, Carlsbad, CA, USA)
and Horse Radish Peroxidase (HRP)-conjugated goat anti-rabbit
and rabbit anti-goat IgG (Invitrogen, Carlsbad, CA, USA).
Plasmid constructs and primers
The pcDNA-optS plasmid was generated from the pcDNA-
optS-FLAG [58] construct. The pGEX-GST-Sendo plasmid is
derived from the pGEX-4T1 plasmid (Pharmacia Biotech,
Uppsala, Sweden) with the S endodomain cDNA inserted in
frame downstream the Glutathione S-Transferase (GST) cDNA.
The pGEX-4T1 based plasmids encoding GST-fused S endodo-
main with truncation of the last 8 or 19 amino-acids (D8 and D19),
cysteine to alanine substitutions (C1, C2, C3, C4 and C1-4), both
C-term truncations and cysteine to alanine substitutions (D8 C1-4
and D19 C1-4), as well as a sequence corresponding to the last 19
residues of S endodomain (DC), and S endodomain T1220A and
K1227A point mutations, were constructed. The pGEX-GST-
FERM encodes the FERM N-terminal domain of ezrin (residues 1
through 309) fused to the GST and was a gift from Dr. Monique
Arpin.
For lentiviral pseudotyped particles (pp) production, the
pNL4.3.Luc R+ E2 lentiviral vector, a gift from Dr. Pierre
Charneau (Institut Pasteur, Paris), was used [59]. The pCI-VSVG
plasmid encodes the sequence for vesicular stomatitis virus (VSV)
G glycoprotein cloned in the pUC19 vector and was kindly
provided by Dr. Garry Nolan (Stanford University, USA). pEGFP-
Vpr, a pEGFP-C1 derived plasmid enabling fusion of HIV Vpr to
GFP [60], was used to produce fluorescent GFP-Vpr SARSpp.
The pcDNA-optSD8 and pCDNA-optSD8-C1 plasmids, which
contain full-length optimized SARS-CoV S genes with D8 or D8
with C1 cysteine to alanine substitutions at the C-terminus
respectively were synthesized and cloned by GeneCust (Dude-
lange, Luxembourg).
For establishment of stable cell lines, pCMV-dR8.91 lentiviral
packaging plasmid [61], pcHMWS-HcRed1, pcHMWS-eGFP-
IRES-puromycin and pcHMWS-eGFP-IRES-hygromycin trans-
fer plasmids, which derive from the original pHR transfer plasmid
[62], were used. pcHMWS-eGFP-ezrinwt-IRES-hygromycin and
pcHMWS-eGFP-ezrinFERM-IRES-hygromycin were generated
from sequences derived from pCB6-ezrin-VSV and pCB6-
ezrinNter-VSV plasmids [26]. The pcHMWS-RFP-ezrinwt-
IRES-hygromycin vector was generated similarly using a modified
vector backbone in which the eGFP gene was replaced by RFP.
pcHMWS-HcRed-IRES-hygromycin and pcHMWS-optS-IRES-
puromycin plasmids were generated from HcRed and SARS-CoV
Spike sequences derived from pcHMWS-HcRed1 and pcDNA-
optS-FLAG plasmids.
Viruses and pseudotyped lentiviral particles
SARS-CoV strain HK39849 was propagated and titrated on
FRhK-4 cells as previously described [63], in Biosafety Level (BSL)
3 laboratory. Lentiviral particles pseudotyped with the SARS-CoV
S (SARSpp), SARS-CoV S with D8 C-terminus deletion (SD8
SARSpp), SARS-CoV S with D8 C-terminus deletion and C1
cluster cysteine to alanine substitutions (SD8 C1 SARSpp), the
VSV G (VSVGpp) envelope glycoproteins, or no envelope
glycoprotein (Denvpp), were generated as previously described
[56,64] in HEK-293T cells. VSVGpp were produced for
generation of cell lines stably expressing GFP (VSVGpp GFP),
HcRed (VSVGpp HcRed), ezrinwt/FERM fused to GFP (VSVGpp
GFP-ezrinwt/FERM), ezrinwt fused to RFP (VSVGpp RFP-ezrinwt),
or SARS-CoV Spike (VSVGpp SARS-CoV Spike).
Yeast two-hybrid screening
Bait cloning and yeast two-hybrid screening were performed by
Hybrigenics (Paris, France). The SARS-CoV S cDNA encoding
the endodomain amino acids 1217–1255 was subcloned in the
pB27 vector enabling fusion of the S endodomain with the LexA
binding domain and transformed in the L40 DGAL4 yeast strain
[65]. A human placenta random-primed cDNA library, trans-
formed into the Y187 yeast strain and containing ten million
independent fragments, was used for mating. One hundred forty
seven million interactions were tested. After selection on medium
lacking leucine, tryptophane, and histidine, 233 positive clones
Implication of Ezrin in SARS Coronavirus Infection
PLOS ONE | www.plosone.org 10 November 2012 | Volume 7 | Issue 11 | e49566
were picked. The corresponding prey fragments were amplified by
PCR and sequenced at their 59 and 39 junctions. Sequences were
then filtered and contiged [60] and compared to the latest release
of the GenBank database using BLASTN [66]. A Predicted
Biological Score was attributed to assess the reliability of the
interaction, as described earlier [67].
GST pull down assays
GST fusion proteins were produced and coupled to Glutathione
Sepharose beads as previously described [33], with minor
modifications. For competition assays, anti-SARS-CoV S endo-
domain rabbit serum was added.
Generation of stable cell lines
Generation of clonal and polyclonal stable cell lines was
performed according to standard procedures. Briefly, Vero E6
or HeLa cells were infected with VSVGpp enabling expression of
different transgenes and selected with hygromycin B at 250 mg/
mL for all cell lines except for HeLa cells expressing both HcRed
and Spike, which were selected on medium containing both
puromycin (5 ng/mL) and hygromycin B (250 mg/mL).
TIRFM analysis of SARSpp entry
Vero E6 cells stably expressing RFP-ezrin were seeded onto
glass bottom petri dishes (MatTek, Ashland MA, USA) and
incubated overnight at 37uC 5% CO2 incubator. The cells were
chilled on ice and concentrated SARSpp GFP-Vpr added at 336
concentration. The particles were left to bind to cells on ice for
30 minutes. The cells were washed three times with medium to
remove unbound particles. To induce endocytosis of particles,
warmed medium was added and the cells were kept in a 37uC
humid chamber mounted on a Zeiss total internal reflection
fluorescence microscope (TIRFM) for 30 minutes before record-
ing. The fluorescent signal from both dyes was then recorded with
intervals of 3 seconds. The incidence angle used was 65 degrees to
enable examination of layer thicknesses of 200 nm and visualiza-
tion of processes at the cell membrane. Fluorescence images were
processed with MetaMorph software (Molecular Devices, Sunny-
vale, CA, USA) and image sequences combined into movies
(Supporting movie S1).
Small interfering RNA treatment
Small interfering RNA (siRNA) reagents used were purchased
from Dharmacon (Lafayette, CO, USA). Ezrin siRNA were
designed from the human cDNA sequence of ezrin (EZR or VIL2
gene, NM_003379). Ezrin siRNA pool corresponds to an
equimolar mix of 4 siRNA duplexes with the following forward
sequences: GCUCAAAGAUAAUGCUAUGUU, GGCAACAG-
CUGGAAACAGAUU, CAAGAAGGCACCUGACUUUUU,
GAUCAGGUGGUAAAGACUAUU. Negative control, non-tar-
geting (NT) siRNAs were used (pool of 4 duplexes). HeLa-F5 cells
were seeded in 96-well plates, at 36103 cells per well. Twenty-four
hours later, a first round of siRNA transfection was performed
using Dharmafect transfection reagent and non-targeting or ezrin
siRNA pools at 100 nM final concentration (Dharmacon). A
second round of transfection was performed 48 hours later.
Analysis of SARSpp entry
For siRNA experiments, forty-eight hours after the second
siRNA treatment, HeLa-F5 cells were infected with lentiviral
pseudotyped particles as described previously [12,64]. Each
condition was performed in quadruplicates. Luciferase activity
was measured forty-eight hours post-infection using the BrightGlo
luciferase substrate (Promega, Madison, WI, USA) and a
MicroBeta JET luminescence counter (Perkin Elmer). Analysis of
knock down of ezrin expression relative to b-actin levels was done
by Western blot of pooled lysates used for luminescence
measurements. For all other experiments involving pseudotyped
particles, cells were infected with the respective pseudotyped
particles and luciferase activity was measured as described above.
SARS-CoV replication analysis
Cells were seeded in 24-well plates at 1.56105 cells per well and
infected with SARS-CoV S strain HK39849 at an M.O.I. of 5.
Three, six and twenty four hours post infection, viral gene
expression was analyzed by quantitative RT-PCR as described
previously [63]. Quantitative RT-PCR analysis was performed
using a Light Cycler 480 (Roche). Levels of viral gene expression
were normalized to cellular 18S rRNA levels.
Immunofluorescence assay of SARS-CoV infected Vero E6
stable cell lines
Vero E6, Vero E6 GFP-ezrinwt and Vero E6 GFP-ezrinFERM
stable cells were seeded on microscopy chamber/slides at 105 cells
per well (Ibidi, Mu¨nchen, Germany). Cells were infected with
SARS-CoV strain HK39849 at M.O.I. of 5. Twenty four hours
after infection, cells were fixed and SARS-CoV S, actin or nuclei
were labeled using specific antibodies, AlexaFluor 555-conjugated
Phalloidin (Invitrogen), or 49,69–diamidino-2-phenylindole
(DAPI), respectively and mounted using Fluoromount G (Southern
Biotech), according to standard procedures. Microscopy observa-
tions and image acquisitions were performed using a Zeiss
AxioObserver Z1 microscope (106 objective). For each cell line
studied, 10 random fields were acquired. Counting of total
number of cells (DAPI or Phalloidin staining) and SARS-CoV
infected cells (S-TRITC staining) was performed by Imaris 6.3
software (Bitplane, Zurich, Switzerland), enabling calculation of
percentage of SARS-CoV infected cells.
Cell-cell fusion assay
HeLa cells stably expressing HcRed or HcRed and Spike were
seeded onto glass coverslips in 24-well plates at a density of
0.756105 cells per well. After 16 hours, Vero E6 cells stably
expressing GFP, GFP-ezrinwt or GFP-ezrinFERM were overlaid at
the same density. Six hours later, cells were treated or not with
10 mg/mL of L-(tosylamido-2-phenyl) ethyl chloromethyl ketone
(TPCK)-treated trypsin (Sigma) at 37uC for 15 minutes to activate
S protein. After addition of FCS-containing medium to inactivate
TPCK trypsin, the cells were incubated for 18 hours at 37uC 5%
CO2, then fixed with 2% PFA, and stained with DAPI. The
coverslips were mounted onto microscopy slides and analyzed
using Zeiss AxioObserver Z1 microscope with 406objective. For
each condition, 10 random fields were acquired and analyzed
using MetaMorph image analysis software (Molecular Devices).
Total number of nuclei (DAPI staining) and number of nuclei
contained in multi-nucleated cells (DAPI/HcRed/GFP positive
cells) were counted, enabling calculation of percentage of nuclei
involved in syncytia formation.
Supporting Information
Movie S1 Ezrin accumulates at sites of entry of SARS-
CoV S-pseudotyped lentiviral particles. Vero E6 cells stably
expressing RFP-ezrinwt were seeded onto a microscopy culture
dish and were inoculated with SARSpp harboring a GFP-tagged
Vpr protein (SARSpp GFP-Vpr) on ice. Unbound particles were
washed with cold medium. The culture dish was then placed in a
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37uC 5% CO2 chamber of a Total Internal Reflection
Fluorescence (TIRF) microscope for 30 minutes to allow for
internalization of particles. After 30 minutes, time-lapse images
were acquired to follow the movements of SARSpp GFP-Vpr
particles during the internalization process at and beneath the
plasma membrane of Vero E6 cells expressing RFP-ezrin. Fifty
frames were acquired at 3 seconds intervals. Scale bar = 40 mm.
(MOV)
Figure S1 Entry of VSV G (VSVGpp), HIV envelope gp
(HIVpp), and Influenza HA (HApp) pseudotyped parti-
cles in ezrin siRNA-treated cells. HeLa P4 (A), and Huh-7
(B) cells were subjected to treatment with ezrin siRNAs as
previously described in the manuscript’s materials and methods
section. The cells were then infected with VSVGpp (A, B), HIVpp
(A), and HApp (B) lentiviral pseudotyped particles. Activity of
luciferase was measured after 72 hours and results correspond to
fold-change compared to entry in non targeting siRNA-treated
cells (average of triplicates).
(TIFF)
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